BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Microtubule-associated protein 1 light chain 3 β (MAP1LC3B; LC3B)

April 28, 2016 7:00 AM UTC

In vitro, cell culture and mouse studies identified a benzo[a]quinolizidine-based agonist of MAP1LC3B that could help treat prostate cancer. Chemical synthesis and in vitro testing of benzo[a]quinoliz...